Table 4.

Univariate and multivariate Cox regression of MYBL2 for overall survival in glioma

	OS
Variable	Univariate analysis		Multivariate analysis
	HR (95% CI)	P-value	HR (95% CI)	P-value
Age (year)
<45 vs. ≥45	0.874 (0.488-1.567)	0.652	0.873 (0.474-1.606)	0.873
Gender
Female vs. male	1.038 (0.617-1.746)	0.889	1.021 (0.590-1.767)	0.941
Clinical Stage
III-IV vs. I-II	1.833(1.395-2.409)	<0.001	0.360 (0.193 -0.670)	<0.05
Tumor Location
Parietal vs. Frontal	1.413 (0.715-2.790)	0.32	0.731 (0.324 -1.650)	0.45
Temporal vs. Frontal	1.173 (0.652-2.110)	0.594	0.995 (0.517-1.914)	0.966
Others vs. Frontal	0.605 (0.297-1.232)	0.166	0.335 (0.308-1.493)	0.301
MYBL2 Expression
Low vs. high	3.619 (2.075-6.313)	<0.001	0.354 (0.193-0.650)	<0.05

HR hazard ratio; CI confidence interval; MYBL2 MYB-related protein B